Literature DB >> 28158423

Sex-specific precision medicine: targeting CRT-D and other cardiovascular interventions to those most likely to benefit.

Viviany R Taqueti1, C Noel Bairey Merz2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28158423      PMCID： PMC5837676          DOI： 10.1093/eurheartj/ehw684

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  17 in total

Review 1.  Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

Authors:  Rachel Huxley; Federica Barzi; Mark Woodward
Journal:  BMJ       Date:  2005-12-21

2.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

3.  Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women.

Authors:  Emily P Zeitler; Anne S Hellkamp; Phillip J Schulte; Gregg C Fonarow; Adrian F Hernandez; Eric D Peterson; Gillian D Sanders; Clyde W Yancy; Sana M Al-Khatib
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

4.  The case for sex- and gender-specific medicine.

Authors:  C Noel Bairey Merz; Vera Regitz-Zagrosek
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

5.  Strategies and Methods for Clinical Scientists to Study Sex-Specific Cardiovascular Health and Disease in Women.

Authors:  Nanette K Wenger; Pamela Ouyang; Virginia M Miller; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

6.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher
Journal:  Eur Heart J       Date:  2012-05-19       Impact factor: 29.983

7.  Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.

Authors:  Robbert Zusterzeel; Kimberly A Selzman; William E Sanders; Daniel A Caños; Kathryn M O'Callaghan; Jamie L Carpenter; Ileana L Piña; David G Strauss
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

8.  The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction.

Authors:  K P Champney; P D Frederick; H Bueno; S Parashar; J Foody; C N B Merz; J G Canto; J H Lichtman; V Vaccarino
Journal:  Heart       Date:  2009-01-15       Impact factor: 5.994

9.  Cardiac-resynchronization therapy for the prevention of heart-failure events.

Authors:  Arthur J Moss; W Jackson Hall; David S Cannom; Helmut Klein; Mary W Brown; James P Daubert; N A Mark Estes; Elyse Foster; Henry Greenberg; Steven L Higgins; Marc A Pfeffer; Scott D Solomon; David Wilber; Wojciech Zareba
Journal:  N Engl J Med       Date:  2009-09-01       Impact factor: 91.245

10.  Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator.

Authors:  Neal A Chatterjee; Rasmus Borgquist; Yuchiao Chang; Jennifer Lewey; Vicki A Jackson; Jagmeet P Singh; Joshua P Metlay; Charlotta Lindvall
Journal:  Eur Heart J       Date:  2017-05-14       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.